Cytomegalovirus Laryngitis in Primary Combined Immunodeficiency Diseases

J Clin Immunol. 2021 Jan;41(1):243-247. doi: 10.1007/s10875-020-00873-9. Epub 2020 Oct 8.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antiviral Agents / therapeutic use
  • Biopsy
  • Child
  • Class Ia Phosphatidylinositol 3-Kinase / genetics
  • Cytomegalovirus Infections / diagnosis*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / etiology*
  • Cytomegalovirus*
  • Disease Management
  • Disease Susceptibility
  • Female
  • Humans
  • Infant
  • Laryngitis / diagnosis*
  • Laryngitis / drug therapy
  • Laryngitis / etiology*
  • Male
  • Mutation
  • Severe Combined Immunodeficiency / complications*
  • Severe Combined Immunodeficiency / etiology
  • Severe Combined Immunodeficiency / immunology
  • Symptom Assessment
  • Treatment Outcome

Substances

  • Antiviral Agents
  • PIK3R1 protein, human
  • Class Ia Phosphatidylinositol 3-Kinase